Check-Cap Ltd — Form F-1/A
Filed August 17, 2026 · analyzed by the Registration Agent
F-1/A
— Neutral
significance 78/100
What the filing says
Check-Cap Ltd (Israeli medical diagnostics company, $7.5M assets) is acquiring MBody AI, an embodied AI robotics-software company, via merger expected Q3 2026. Check-Cap shareholders will own ~10% post-merger; MBody AI shareholders ~90%. Concurrently, Check-Cap is raising $12.5M (1.43M shares at $8.72/share) for merger expenses, robot deployments, and platform development. The company also acquired Ghost Kitchen franchise rights in New Jersey for 1.17M shares on Sept 4, 2025. Pending Nasdaq listing approval; going-concern doubt disclosed.
Why this rating
Transformational for Check-Cap's ~$7.5M base (90% dilution to legacy shareholders, new business model). MBody AI profitable 2025 but negative cash flow; high customer concentration (MGM, Caesars). Merger is real but contingent on Nasdaq approval. Material but execution risk remains.
See more from August 17, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.